Nymox Pharmaceutical
NYMX
#7607
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-47.37%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Total debt
Total debt on the balance sheet as of June 2023 : $0.8 M
According to Nymox Pharmaceutical's latest financial reports the company's total debt is $0.8 M. A company’s total debt is the sum of all current and non-current debts.
Nymox Pharmaceutical - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.17 M | -55.75% |
| 2021-12-31 | $0.39 M | -8.22% |
| 2020-12-31 | $0.42 M | 189.8% |
| 2019-12-31 | $0.14 M | |
| 2016-12-31 | $0.93 M | 14.26% |
| 2015-12-31 | $0.81 M | 13.33% |
| 2014-12-31 | $0.71 M | |
| 2008-12-31 | $0.01 M | -37.5% |
| 2007-12-31 | $0.02 M | -95.21% |
| 2006-12-31 | $0.53 M | -1.77% |
| 2005-12-31 | $0.54 M | -9.18% |
| 2004-12-31 | $0.6 M | 20% |
| 2003-12-31 | $0.5 M | -8.24% |
| 2002-12-31 | $0.54 M | 37.33% |
| 2001-12-31 | $0.39 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $52.90 B | 6,572,198.14% | 🇺🇸 USA |
 Pfizer PFE | $34.92 B | 4,338,657.76% | 🇺🇸 USA |
 Abbott Laboratories ABT | $16.90 B | 2,099,278.88% | 🇺🇸 USA |
 Eli Lilly LLY | $18.82 B | 2,337,788.20% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $4.95 B | 615,924.84% | 🇺🇸 USA |